US4960757A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Pasteurized human fibrinogen (HF), a process for its preparation, and its use
Assignee: Siemens Healthcare Diagnostics GmbH Germany
•
Filing: 1988-08-01
•
Granted: 1990-10-02
•
Expires: 2008-08-01
Abstract
Abstract A pasteurized human firbinogen which can be used therapeutically, and a process for its preparation are described.
Inventors
- 👤 Gerhardt Kumpe
- 👤 Wilfried Wormsbacher
- 👤 Norbert Heimburger
- 👤 Peter Fuhge
- 👤 Hans M. Preis
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 06:16
CPC Classifications
A; A61; A61K; A61K35/00; A61K35/12; A61K35/14; A61K38/00; A61K38/16; A61K38/17; A61K38/36; A61K38/363; A61L; A61L2/00; A61L2/02; A61L2/04; A61L2103/00; A61L2103/05; A61L2103/09
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
82 words
A process for the pasteurization of human fibrinogen comprising the step of heating, at a temperature between 60° to 100° C. for 10 to 24 hours, an aqueous solution of human fibrinogen in the presence of (a) a thermally stabilizing amount of a carbohydrate selected from the group consisting of monosaccharide, oligosaccharide, sugar alcohol, and mixtures thereof, (b) an amino acid or mixture of amino acids, and (c) calcium ions in a concentration of 1 to 37,800 g atoms/mole of human fibrinogen.
Claim 2
Dependent Claim
82 words
A process for the pasteurization of human fibrinogen comprising the step of heating, at a temperature between 60° to 100° C. for 10 to 24 hours, an aqueous solution of human fibrinogen in the presence of (a) a thermally stabilizing amount of a carbohydrate selected from the group consisting of monosaccharide, oligosaccharide, sugar alcohol, and mixtures thereof, (b) an amino acid or mixture of amino acids, and (c) calcium ions in a concentration of 1 to 37,800 g atoms/mole of human fibrinogen.
Claim 3
Dependent Claim
22 words
The process as claimed in claim 1, wherein the concentration of calcium ions is 1 to 10 g atoms/mole of human fibrinogen.
Claim 4
Dependent Claim
9 words
Pasteurized human fibrinogen produced in accordance with claim 1.
Claim 5
Dependent Claim
14 words
A human intravenous infusion solution comprising pasteurized human fibrinogen as claimed in claim 3.
Claim 6
Dependent Claim
20 words
A process for producing adhesion between living human tissues comprising application of pasteurized human fibrinogen as claimed in claim 3.
Claim 7
Dependent Claim
22 words
The process as claimed in claim 1, wherein said aqueous solution of human fibrinogen has a concentration of 1 to 7% (w/v).
Claim 8
Dependent Claim
103 words
In a process for the pasteurization of human fibrinogen by heating an aqueous solution of human fibrinogen in the presence of (a) a thermally stabilizing amount of a carbohydrate selected from the group consisting of monosaccharide, oligosaccharide, sugar alcohol, and mixtures thereof and (b) a thermally stabilizing amount of an amino acid or a mixture of amino acids, the improvement comprising heating the aqueous solution of human fibrinogen between 10 to 24 hours at a temperature of between 60° to 100° C. in the additional presence of calcium ions in a concentration of 1 to 37,800 g atoms per mole of human fibrinogen.
Claim 9
Dependent Claim
103 words
In a process for the pasteurization of human fibrinogen by heating an aqueous solution of human fibrinogen in the presence of (a) a thermally stabilizing amount of a carbohydrate selected from the group consisting of monosaccharide, oligosaccharide, sugar alcohol, and mixtures thereof and (b) a thermally stabilizing amount of an amino acid or a mixture of amino acids, the improvement comprising heating the aqueous solution of human fibrinogen between 10 to 24 hours at a temperature of between 60° to 100° C. in the additional presence of calcium ions in a concentration of 1 to 37,800 g atoms per mole of human fibrinogen.
Claim 10
Dependent Claim
30 words
The process as claimed in claim 7 wherein the improvement further comprises adding the calcium ions, carbohydrates, and amino acids in the following sequence: calcium ions, carbohydrates, and amino acids.
Claim 11
Dependent Claim
27 words
The process as claimed in claim 8, wherein the improvement further comprises pasteurizing an aqueous solution of human fibrinogen having a concentration of 1 to 7% (w/v).
Claim 12
Dependent Claim
22 words
The process as claimed in claim 8, wherein the concentration of calcium ions is 1 to 10 g atoms/mole of human fibrinogen.
Claim 13
Dependent Claim
70 words
The process as claimed in claim 7 wherein the improvement further comprises heating the aqueous solution of human fibrinogen in the presence of (a) a carbohydrate consisting of sucrose in a concentration of 35 to 60 g/100 ml of solution, (b) an amino acid consisting of glycine in a concentration of 0.50 to 3 moles/liter, and (c) calcium ions in concentration of 1 to 10 g atoms/mole of human fibrinogen.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-10-01 | 1994-04-02 | 1994-10-02 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-10-01 | 1998-04-02 | 1998-10-02 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-10-01 | 2002-04-02 | 2002-10-02 | $7700.00 | Window Closed / Lapsed |